Treatment of Obstructive Sleep Apnea in Children: An Opportunity for Cardiovascular Risk Modification

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
ObesityObstructive Sleep ApneaSleep DisordersCardiovascular Disease
Interventions
DEVICE

cPAP

All participants diagnosed with obstructive sleep apnea will be required to use cPAP for 6 months prior to the RCT component of this trial

DEVICE

cPAP, Continuation

Participants will be randomized to continue cPAP for a 2 week period

DEVICE

cPAP, Discontinuation

Participants will be randomized to discontinue cPAP for a 2 week period

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT02403492 - Treatment of Obstructive Sleep Apnea in Children: An Opportunity for Cardiovascular Risk Modification | Biotech Hunter | Biotech Hunter